Sign In
Buy BAYRY
$13.89
-0.110 (-0.786%)
At Close: Jul 31, 2026
Bayer (BAYRY) & Cedilla to Co-Develop Novel Cancer Therapies
08:23am, Friday, 02'nd Jun 2023
Bayer (BAYRY) announces licensing agreement with Cedilla Therapeutics to jointly develop and commercialize the latter's selective protein complex inhibitors as novel cancer therapies.
Bayer's (BAYRY) Arrhythmia Prevention Drug Gets Fast Track Tag
12:47pm, Wednesday, 17'th May 2023
Bayer's (BAYRY) oral FXIa inhibitor, asundexian, gets the FDA's Fast Track Designation, as a preventive treatment for stroke and systemic embolism in people with atrial fibrillation.
Bayer (BAYRY) Q1 Earnings Beat, Crop Science Sales Decline
02:26pm, Thursday, 11'th May 2023
Bayer (BAYRY) tops on first-quarter 2023 earnings but misses on sales. Management reiterates guidance.
DAX index analysis after mixed Bayer, Deutsche Telekom earnings
02:37am, Thursday, 11'th May 2023
European stock indices have done well in the past few months as the fear of a recession in the region have abated. In Germany, the DAX index jumped to €16,000, the highest point since January 2022.
Bayer AG Still Dirt-Cheap, Investors Are Getting Its Pharma Business For 'Free'
12:00am, Tuesday, 02'nd May 2023
Bayer stock is a textbook example of investing in a wonderful company at a fair price with an estimated upside potential between 30% - 120%. The group is suffering from a conglomerate discount and inv
My Dividend Stock Portfolio: New All-Time Dividend Record - 99 Holdings With 25 Buys
10:00am, Wednesday, 12'th Apr 2023
Inflation and (expected) actions by the Federal Reserve continue to dominate market movements even though the turmoil in the financial sector shortly took center stage. Markets have started the new ye
International Wide-Moat Stocks On Sale - The April 2023 Heat Map
02:16am, Saturday, 08'th Apr 2023
Our 3-step process focuses on wide-moat stocks (as per Morningstar's rating). We are only interested in those targets that are attractively valued in historical comparison.
Searching For Potential German Portfolio Winners
07:00am, Friday, 24'th Mar 2023
With 2-5 year U.S. Treasury securities currently yielding 3-4%, it makes great sense to search for equities that offer us both a competitive dividend with possible upside potential. Add to that divers
International Wide-Moat Stocks On Sale - The March 2023 Heat Map
12:56am, Wednesday, 08'th Mar 2023
Our 3-step process focuses on wide-moat stocks (as per Morningstar's rating). We are only interested in those targets that are attractively valued in historical comparison.
My Dividend Stock Portfolio: New February Record - 99 Holdings With 32 Buys And 4 Sales
09:15am, Tuesday, 07'th Mar 2023
Inflation and (expected) actions by the Federal Reserve continue to dominate market movements. Markets have started the new year with very solid gains following expectations about a more dovish Federa
Bayer's (BAYRY) Q4 Earnings and Revenues Top, Outlook Weak
03:04pm, Tuesday, 28'th Feb 2023
Bayer (BAYRY) beats on earnings and sales in the fourth quarter. However, its 2023 outlook is dismal.
Bayer AG (BAYZF) Q4 2022 Earnings Call Transcript
01:40pm, Tuesday, 28'th Feb 2023
Bayer AG (OTCPK:BAYZF) Q4 2022 Results Earnings Conference Call February 28, 2023 8:00 AM ET Company Participants Oliver Maier - Head of Investor Relations Werner Baumann - Chairman, Chief Executive O
Bayer share price has nosedived: is it a good turnaround stock?
05:44am, Tuesday, 28'th Feb 2023
Bayer (ETR: BAYN) share price plunged to the lowest level since February 6 after the company lowered its forward guidance. It retreated to a low of €55.95, which was about 15% below the highest leve
Bayer shares slide on lower fourth-quarter net profit; weedkiller claims rose in 2022
05:19am, Tuesday, 28'th Feb 2023
Bayer AG shares BAYN, -4.66% fell on Tuesday after the company said fourth-quarter net profit fell, noting that it had a higher number of lawsuits related to its allegedly harmful weedkiller Roundup i
Bayer warns on 2023 earnings as inflation remains high, after disappointing quarter
02:36am, Tuesday, 28'th Feb 2023
Bayer AG on Tuesday reported net profit for the fourth quarter of 2022 that missed consensus expectations despite higher sales, and said it expects earnings for 2023 to be lower than the prior year as
